Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe - EPA:COVH - FR0000060303 - REIT

24.8 EUR
+0.3 (+1.22%)
Last: 10/8/2025, 7:00:00 PM
Fundamental Rating

4

Overall COVH gets a fundamental rating of 4 out of 10. We evaluated COVH against 42 industry peers in the Diversified REITs industry. Both the profitability and the financial health of COVH get a neutral evaluation. Nothing too spectacular is happening here. COVH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year COVH was profitable.
In the past year COVH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: COVH reported negative net income in multiple years.
COVH had a positive operating cash flow in each of the past 5 years.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.89%, COVH is in line with its industry, outperforming 57.14% of the companies in the same industry.
The Return On Equity of COVH (5.88%) is better than 64.29% of its industry peers.
COVH's Return On Invested Capital of 3.68% is fine compared to the rest of the industry. COVH outperforms 61.90% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COVH is in line with the industry average of 3.40%.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With an excellent Profit Margin value of 78.96%, COVH belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Profit Margin of COVH has declined.
COVH has a better Operating Margin (101.55%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COVH is destroying value.
Compared to 1 year ago, COVH has about the same amount of shares outstanding.
Compared to 5 years ago, COVH has more shares outstanding
The debt/assets ratio for COVH is higher compared to a year ago.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that COVH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of COVH (1.06) is better than 66.67% of its industry peers.
COVH has a debt to FCF ratio of 12.72. This is a negative value and a sign of low solvency as COVH would need 12.72 years to pay back of all of its debts.
With a Debt to FCF ratio value of 12.72, COVH perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, COVH perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Altman-Z 1.06
ROIC/WACC0.68
WACC5.44%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
COVH has a better Current ratio (1.16) than 88.10% of its industry peers.
A Quick Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
COVH has a Quick ratio of 1.16. This is amongst the best in the industry. COVH outperforms 88.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 241.67%, which is quite impressive.
COVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.16% yearly.
Looking at the last year, COVH shows a decrease in Revenue. The Revenue has decreased by -5.26% in the last year.
Measured over the past years, COVH shows a small growth in Revenue. The Revenue has been growing by 2.29% on average per year.
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

COVH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.90% yearly.
Based on estimates for the next years, COVH will show a small growth in Revenue. The Revenue will grow by 0.55% on average per year.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.97, which indicates a rather expensive current valuation of COVH.
COVH's Price/Earnings ratio is in line with the industry average.
COVH's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.91.
A Price/Forward Earnings ratio of 14.39 indicates a correct valuation of COVH.
COVH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. COVH is more expensive than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of COVH to the average of the S&P500 Index (23.30), we can say COVH is valued slightly cheaper.
Industry RankSector Rank
PE 17.97
Fwd PE 14.39
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COVH is on the same level as its industry peers.
61.90% of the companies in the same industry are cheaper than COVH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.94
EV/EBITDA 17.59
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.97
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.95%, COVH is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.55, COVH pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, COVH pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.95%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

19.16% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
DP19.16%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (10/8/2025, 7:00:00 PM)

24.8

+0.3 (+1.22%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-16 2025-07-16
Earnings (Next)10-22 2025-10-22
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.92B
Analysts82.86
Price Target18.67 (-24.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.95%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.16%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.97
Fwd PE 14.39
P/S 15.04
P/FCF 16.94
P/OCF 10.72
P/B 1.12
P/tB 1.23
EV/EBITDA 17.59
EPS(TTM)1.38
EY5.56%
EPS(NY)1.72
Fwd EY6.95%
FCF(TTM)1.46
FCFY5.9%
OCF(TTM)2.31
OCFY9.33%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.97
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.74%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexcg growth 3Y33.75%
ROICexcg growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Debt/EBITDA 6.97
Cap/Depr 152.56%
Cap/Sales 51.52%
Interest Coverage 4.11
Cash Conversion 103.65%
Profit Quality 112.39%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.06
F-Score5
WACC5.44%
ROIC/WACC0.68
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.29%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%